ABCL
AbCellera Biologics Inc. · $5.71 (+0.4%) · mkt cap $1.7B
15 hub catalysts across 3 sources · backtest → · ← Ticker Explorer
FINRA Short VolumeSEC EDGAR FilingsStockTwits Social Sentiment
Signal summary
Signals divergeBullish and bearish forces are in conflict here — weigh both columns.
100▲ Bullishconviction from hub signals
Bullish factors
- StockTwits 90% bullish
- 2 analyst upgrades
- Insiders net buying (9 vs 0)
Bearish factors
- 2 analyst downgrades
Context (not directional): Short volume 1% of float-traded
Signal mix for ABCL
Which data feeds have fired on this name — hover a slice for counts.
Best strategy
2-yr backtest · by SharpeBuy & Hold (baseline) has fit ABCL best over 2 years (+87.2%, Sharpe 0.79). Historical/in-sample — walk-forward all 19 →
| # | Strategy | Return | Sharpe | Beats B&H |
|---|---|---|---|---|
| 1 | Buy & Hold (baseline) | +87.2% | 0.79 | |
| 2 | RSI Mean-Reversion | +33.0% | 0.57 | |
| 3 | Stochastic Oscillator | +22.5% | 0.52 |
Price — 1 year
daily closeInsider activity
9 open-market buysOfficers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.
| Date | Action | Insider | Shares | Value |
|---|---|---|---|---|
| 2026-05-14 | BUY | Montalbano John S. | 20,000 | $95K |
| 2026-02-27 | BUY | Thermopylae Holdings, Ltd. | 38,000 | $131K |
| 2026-02-27 | BUY | Booth Andrew | 42,600 | $146K |
| 2026-02-26 | BUY | Thermopylae Holdings, Ltd. | 177,457 | $580K |
| 2025-11-26 | BUY | Montalbano John S. | 50,000 | $178K |
| 2025-03-11 | BUY | Thermopylae Holdings, Ltd. | 343,631 | $742K |
| 2025-03-10 | BUY | Montalbano John S. | 25,000 | $58K |
| 2025-03-06 | BUY | Montalbano John S. | 60,000 | $141K |
| 2024-08-29 | BUY | Thermopylae Holdings, Ltd. | 283,516 | $740K |
Analyst ratings
live · 12 changes| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| 2026-07-07 | Upgrade | Benchmark | Hold → Buy |
| 2026-05-05 | Initiated | Cantor Fitzgerald | Overweight |
| 2026-04-10 | Initiated | Jones Trading | Buy |
| 2025-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-08-20 | Downgrade | Benchmark | Buy → Hold |
| 2024-02-22 | Upgrade | Benchmark | Hold → Buy |
| 2023-12-05 | Initiated | Keybanc | Overweight |
| 2023-02-28 | Initiated | Cowen & Co. | Outperform |
| 2022-12-15 | Initiated | Goldman Sachs | Buy |
| 2022-11-16 | Initiated | Truist Securities | Buy |
| 2021-12-21 | Initiated | Benchmark | Buy |
| 2021-11-19 | Initiated | Piper Sandler | Overweight |
Catalyst timeline
15 hub signals| Date | Source | Event | Entity | Value | |
|---|---|---|---|---|---|
| 2026-08-01 | StockTwits Social Sentiment | Social Buzz | AbCellera Biologics Inc | 90% bull | source ↗ |
| 2026-07-30 | StockTwits Social Sentiment | Social Buzz | AbCellera Biologics Inc | 93% bull | source ↗ |
| 2026-07-29 | SEC EDGAR Filings | 8-K Event | AbCellera Biologics Inc. | source ↗ | |
| 2026-07-19 | StockTwits Social Sentiment | Social Buzz | AbCellera Biologics Inc | 91% bull | source ↗ |
| 2026-07-06 | SEC EDGAR Filings | 8-K Event | AbCellera Biologics Inc. | source ↗ | |
| 2026-07-02 | FINRA Short Volume | Short Vol | ABCL | 52% short | source ↗ |
| 2026-07-01 | FINRA Short Volume | Short Vol | ABCL | 54% short | source ↗ |
| 2026-06-29 | FINRA Short Volume | Short Vol | ABCL | 55% short | source ↗ |
| 2026-06-26 | FINRA Short Volume | Short Vol | ABCL | 62% short | source ↗ |
| 2026-06-25 | FINRA Short Volume | Short Vol | ABCL | 57% short | source ↗ |
| 2026-06-24 | FINRA Short Volume | Short Vol | ABCL | 58% short | source ↗ |
| 2026-06-18 | FINRA Short Volume | Short Vol | ABCL | 57% short | source ↗ |
| 2026-06-17 | SEC EDGAR Filings | 8-K Event | AbCellera Biologics Inc. | source ↗ | |
| 2026-06-12 | SEC EDGAR Filings | 8-K Event | AbCellera Biologics Inc. | source ↗ | |
| 2026-06-05 | SEC EDGAR Filings | 8-K Event | AbCellera Biologics Inc. | source ↗ |
Alt-Data Signal Hub · collected signals updated 2026-08-01 10:45 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice